Jamieson Wellness Inc

Jamieson Wellness Inc

JWEL · TO · Consumer Defensive / Packaged Foods

45.69CAD+0.01 (+0.02%)

Price History

Full chart

Market Stats

Previous Close45.68
Open45.68
Day Range45.67 – 45.70
52-Week Range31.95 – 45.88
Volume82.96K
Market Cap1.89B
P/E (TTM)24.83
Forward P/E18.12
EPS1.83
Dividend Yield2.20%
Beta0.95
50-Day Avg44.75
200-Day Avg38.09

About

Jamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells the natural health products for human in Canada, the United States, China, and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products, including vitamins, minerals, and supplements as well as sports nutrition products. The Strategic Partners segment provides contract manufacturing services to consumer health companies and retailers. It offers health and wellness supplements under the Jamieson brand; health, beauty, and wellness supplements under the Youtheory brand; and foundational formulas, including probiotics, multivitamins, fish oils, vitamin D, and solution-focused products for better sleep or digestion under the Progressive brand. The company also provides plant-based products under the Iron Vegan brand; natural health products for health concerns among women comprising hormone imbalances, nutrient deficiencies, sleep and stress management, and others under the Smart Solutions brand; and sports nutrition supplements under the Precision brand. It sells its products to distributors, retail, and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.

Company Details

  • SectorConsumer Defensive
  • IndustryPackaged Foods
  • CEOMr. Michael Pilato
  • Employees0
  • Headquarters1 Adelaide Street East, Toronto, ON, Canada, M5C 2V9, Canada
  • Websitehttps://www.jamiesonwellness.com

Leadership

  • Mr. Michael PilatoPresident, CEO & Director · b. 1975
  • Mr. Christopher Snowden CPAChief Financial Officer
  • Ms. Regan StewartChief Operating Officer
  • Mr. John DohertyChief Science & Innovation Officer · b. 1973
  • Ms. Ruth WinkerVice President of Corporate Affairs & Investor Relations
  • Ms. Tara MartinSenior VP, General Counsel & Corporate Secretary
  • Mr. Eric BentzExecutive VP of Global Marketing & MD of Canada
  • Ms. Nicole StuartSenior Vice President of People & Culture
  • Mr. Paul GalbraithExecutive VP & MD of USA
  • Mr. Joel ScalesExecutive VP and MD of Jamieson International & Global Strategy

Financials

Income Statement

Currency: CAD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue193.22M230.87M248.33M300.62M319.78M344.98M403.66M451.03M547.37M676.17M733.78M822.06M
Growth (%)-+19.48%+7.57%+21.06%+6.37%+7.88%+17.01%+11.74%+21.36%+23.53%+8.52%+12.03%
Cost of Revenue141.56M152.97M167.52M195.77M204.36M215.25M258.90M288.59M349.03M442.61M458.17M483.72M
Gross Profit51.65M77.90M80.81M104.85M115.42M129.73M144.76M162.44M198.34M233.56M275.61M338.33M
Gross Margin26.73%33.74%32.54%34.88%36.09%37.61%35.86%36.02%36.23%34.54%37.56%41.16%
Operating Expense40.97M52.37M49.77M59.91M65.33M74.28M81.18M86.41M115.15M146.17M169.33M224.57M
Operating Income10.69M25.53M31.04M44.94M50.09M55.45M63.57M76.03M83.19M87.39M106.28M113.76M
Operating Margin5.53%11.06%12.50%14.95%15.66%16.07%15.75%16.86%15.20%12.92%14.48%13.84%
EBITDA17.20M32.79M38.59M53.44M59.14M61.92M75.76M90.30M100.44M102.88M114.60M135.33M
EBITDA Margin8.90%14.20%15.54%17.78%18.49%17.95%18.77%20.02%18.35%15.21%15.62%16.46%
Net Income-33.18M-95.38M-25.17M-23.79M26.67M31.66M41.60M52.08M52.81M47.88M51.91M62.44M
Net Income Margin-17.17%-41.32%-10.13%-7.91%8.34%9.18%10.31%11.55%9.65%7.08%7.07%7.60%
Interest Expense20.92M22.90M21.96M243.00K7.55M8.29M6.04M5.66M12.42M22.78M20.27M25.84M
Interest Expense % of Total Revenue10.83%9.92%8.84%0.08%2.36%2.40%1.50%1.25%2.27%3.37%2.76%3.14%

Balance Sheet

Currency: CAD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets403.51M403.87M405.18M512.55M549.02M561.77M609.34M652.48M1.11B1.14B1.21B1.22B
Total Liabilities436.55M528.96M556.78M291.73M308.30M302.61M316.94M310.45M675.67M662.38M660.41M685.52M
Total Equity-33.05M-125.09M-151.60M220.82M240.72M259.17M292.40M342.02M431.59M438.93M505.18M485.42M
Cash6.85M2.33M15.88M4.83M12.45M198.00K1.17M6.78M26.24M36.86M44.79M41.23M
Total Debt273.27M264.27M260.03M163.21M165.91M174.24M185.54M170.00M461.93M462.99M308.29M472.02M
Net Debt266.42M261.95M244.15M158.38M153.47M164.57M147.89M142.35M373.76M426.12M263.50M430.80M

Cash Flow

Currency: CAD2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow9.85M18.01M29.01M17.84M27.80M16.40M40.60M44.41M50.59M31.71M61.58M82.51M
Investing Cash Flow-324.76M-4.87M-4.71M-87.49M-11.54M-9.50M-13.17M-22.28M-256.53M-35.13M-10.16M-22.25M
Financing Cash Flow321.76M-17.66M-10.74M58.59M-8.66M-19.14M-26.46M-16.51M225.41M14.04M-45.43M-62.78M
Capital Expenditure1.95M4.87M4.71M4.99M11.54M9.50M13.17M22.28M14.57M9.31M10.16M12.71M
Free Cash Flow7.90M13.14M24.30M12.86M16.27M6.90M27.43M22.12M36.02M22.41M51.41M69.80M
Dividends Paid15.64M15.64M15.64M15.64M12.94M14.69M18.64M22.11M26.32M30.26M33.46M37.18M
FCF to OCF80.23%72.96%83.76%72.06%58.51%42.07%67.56%49.82%71.20%70.65%83.49%84.60%
Dividend Paid to FCF197.94%119.01%64.35%121.60%79.51%212.92%67.95%99.94%73.08%135.05%65.08%53.27%

Earnings

Report DateAug 9, 2017Nov 9, 2017Feb 22, 2018May 9, 2018Aug 8, 2018Nov 6, 2018Feb 27, 2019May 8, 2019Aug 8, 2019Nov 6, 2019Feb 20, 2020May 13, 2020Aug 12, 2020Nov 5, 2020Feb 25, 2021May 5, 2021Aug 5, 2021Nov 4, 2021Feb 24, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Feb 23, 2023May 4, 2023Aug 3, 2023Nov 2, 2023Mar 13, 2024May 9, 2024Aug 8, 2024Nov 7, 2024Mar 11, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Feb 26, 2026May 7, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate0.120.190.250.140.190.250.310.150.180.220.350.200.210.270.400.210.270.350.470.220.290.380.630.180.330.300.730.040.330.360.800.110.350.390.910.140.410.49
EPS Actual0.020.220.250.150.170.220.310.160.200.240.360.190.240.300.420.220.290.340.490.260.320.340.620.210.320.350.670.090.350.370.800.140.400.410.900.170.46-
Surprise-83.33%15.79%0.00%7.14%-10.53%-12.00%0.00%6.67%11.11%9.09%2.86%-5.00%14.29%11.11%5.00%4.76%7.41%-2.86%4.26%18.18%10.34%-10.53%-1.59%16.67%-3.03%16.67%-8.22%125.00%6.06%2.78%0.63%27.27%14.29%5.13%-1.10%21.43%12.20%-
TimingAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap1.89B
Enterprise Value2.30B
Trailing P/E24.83
Forward P/E18.12
Price / Sales2.14
Price / Book3.70
EPS1.83
Book Value12.28
Revenue (TTM)880.58M
Gross Profit (TTM)368.78M
EBITDA146.10M
Profit Margin8.92%
Operating Margin12.66%
Return on Equity15.25%
Return on Assets6.79%
Shares Outstanding41.49M
Shares Float41.09M
Beta0.95
Dividend Yield2.20%
Dividend Rate1.00
Payout Ratio48.45%

Dividends

20263×
0.25Aug 31, 20260.23Jun 1, 20260.23Mar 6, 2026
20254×
0.23Dec 1, 20250.23Aug 29, 20250.21May 30, 20250.21Mar 7, 2025
20244×
0.21Nov 29, 20240.21Aug 30, 20240.19May 31, 20240.19Feb 29, 2024
20234×
0.19Nov 30, 20230.19Aug 31, 20230.17May 31, 20230.17Mar 2, 2023
20224×
0.17Nov 30, 20220.17Aug 30, 20220.15May 30, 20220.15Mar 3, 2022
20214×
0.15Nov 30, 20210.15Aug 30, 20210.13May 28, 20210.13Mar 4, 2021
20201×
0.13Nov 30, 2020

Stock Splits

  • Oct 27, 20231:16